| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T425 |
0-92 |
Sentence |
denotes |
A large number of clinical trials using experimental antiviral drugs are currently underway. |
| T426 |
93-454 |
Sentence |
denotes |
A small proportion of them are aimed at repurposing existing antivirals, including arbidol (umifenovir), a broad-spectrum antiviral that blocks viral fusion; lopinavir/ritonavir (LPV/r), a combination of anti-HIV protease inhibitors; favipiravir, an RdRp inhibitor used to treat severe influenza infections (Hayden and Shindo, 2019); and remdesivir (Figure 6A). |
| T427 |
455-620 |
Sentence |
denotes |
Chen et al. conducted a multicenter, randomized priority trial on 240 patients with confirmed COVID-19 infection to test favipiravir or arbidol (Chen et al., 2020b). |
| T428 |
621-687 |
Sentence |
denotes |
Favipiravir was suggested to significantly improve symptom relief. |
| T429 |
688-870 |
Sentence |
denotes |
However, the interpretation of this study is limited by a short clinical recovery window of 7 days, only 100 of 236 patients with confirmed COVID-19, and the lack of a control group. |
